Koers Bausch Health Companies Inc Toronto S.E.
Aandelen
CA91911K1021
Farmaceutische producten
Omzet 2024 * | 9,4 mld. 12,84 mld. 8,72 mld. | Omzet 2025 * | 9,67 mld. 13,21 mld. 8,97 mld. | Marktkapitalisatie | 2,52 mld. 3,45 mld. 2,34 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 148 mln. 202 mln. 137 mln. | Nettowinst (verlies) 2025 * | 389 mln. 532 mln. 361 mln. | EV/omzet 2024 * | 2,44 x |
Nettoschuld 2024 * | 20,44 mld. 27,94 mld. 18,98 mld. | Nettoschuld 2025 * | 19,09 mld. 26,09 mld. 17,72 mld. | EV/omzet 2025 * | 2,24 x |
K/w-verhouding 2024 * |
20,4
x | K/w-verhouding 2025 * |
6,53
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,62% |
Recentste transcriptie over Bausch Health Companies Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 24-05-22 |
Chief Operating Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 01-08-08 |
John Paulson
CHM | Chairman | 68 | 01-06-17 |
Steven Miller
BRD | Director/Board Member | 35 | 17-03-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+30,38% | 684 mld. | |
+26,51% | 568 mld. | |
-4,36% | 361 mld. | |
+19,30% | 329 mld. | |
+3,73% | 284 mld. | |
+16,70% | 240 mld. | |
+8,78% | 208 mld. | |
-7,93% | 200 mld. | |
+7,68% | 166 mld. |